UW Program for Advanced Cell Therapy
Business Services · Wisconsin, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1111 Highland Ave Wimr Fl 3, Madison, Wi...Website
pact.wisc.eduRevenue
$5.9 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About UW Program for Advanced Cell Therapy
The Program for Advanced Cell Therapy (PACT) at UW-Madison specializes in integrated personalized cell technologies aimed at improving health outcomes for children and adults with unmet medical needs. Their mission focuses on developing healthcare-friendly solutions for novel cell therapies and devices, emphasizing quality and excellence in FDA-compliant cell manufacturing. PACT conducts first-in-human clinical trials and collaborates with academic and industry partners to translate scientific discoveries into effective cell therapies. The program operates under strict Good Manufacturing Practices, ensuring high standards in their ISO-certified facilities.Explore more
UW Program for Advanced Cell Therapy Org Chart
OG
Cell Manufacturing Specialist
XT
Process Development & Manufacturing Scientist...
SM
Process Development & Manufacturing Scientist
JM
Process Development & Manufacturing Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is UW Program for Advanced Cell Therapy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
UW Program for Advanced Cell Therapy, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at UW Program for Advanced Cell Therapy
Funding: Get notified immidiatlly once UW Program for Advanced Cell Therapy has new funding data
Website visits: Recent activity has been detected on your website
Check out if UW Program for Advanced Cell Therapy is spiking on competitors!
Check if UW Program for Advanced Cell Therapy has recently received funding, and reach out quickly before it becomes old news!
Click to see if UW Program for Advanced Cell Therapy had a recent Job posting/layoffs
Product Launch: Get notified when UW Program for Advanced Cell Therapy launches new products
Earning: See what the market has to say on UW Program for Advanced Cell Therapy recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined UW Program for Advanced Cell Therapy as Masked Content
Find 2 more new buyers
Compare Similar Companies to UW Program for Advanced Cell Therapy
Compare insights from companies similar to UW Program for Advanced Cell Therapy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
UW Program for Advanced Cell Therapy is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
UW Program for Advanced Cell Therapy is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about UW Program for Advanced Cell Therapy.
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding UW Program for Advanced Cell Therapy
Sign Up For FreeTo access detailed company insights
The Program for Advanced Cell Therapy (PACT) at UW-Madison specializes in integrated personalized cell technologies aimed at improving health outcomes for children and adults with unmet medical needs. Their mission focuses on developing healthcare-friendly solutions for novel cell therapies and devices, emphasizing quality and excellence in FDA-com... Read More
